<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">[]. </span>
   <span class="font23">melanoma </span>
   <span class="font21">tumor </span>
   <span class="font20">virus </span>
   <span class="font19">cancer </span>
   <span class="font18">patients </span>
   <span class="font18">oncolytic </span>
   <span class="font18">therapy </span>
   <span class="font17">cells </span>
   <span class="font17">gene </span>
   <span class="font17">cell </span>
   <span class="font16">human </span>
   <span class="font16">treatment </span>
   <span class="font15">vector </span>
   <span class="font15">phase </span>
   <span class="font15">clinical </span>
   <span class="font14">expression </span>
   <span class="font14">using </span>
   <span class="font14">vectors </span>
   <span class="font13">disease </span>
   <span class="font13">malignant </span>
   <span class="font13">immune </span>
   <span class="font13">responses </span>
   <span class="font13">viral </span>
   <span class="font13">{border-style </span>
   <span class="font13">expressing </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">NDV </span>
   <span class="font13">RNA </span>
   <span class="font12">Cancer </span>
   <span class="font12">Melanoma </span>
   <span class="font12">TVEC </span>
   <span class="font12">breast </span>
   <span class="font12">metastatic </span>
   <span class="font12">reovirus </span>
   <span class="font12">trial </span>
   <span class="font12">viruses </span>
   <span class="font12">Gene </span>
   <span class="font12">survival </span>
   <span class="font12">targeting </span>
   <span class="font12">vaccine </span>
   <span class="font12">CVA </span>
   <span class="font12">administration </span>
   <span class="font12">advanced </span>
   <span class="font12">combination </span>
   <span class="font12">efficacy </span>
   <span class="font12">herpes </span>
   <span class="font12">mice </span>
   <span class="font12">recombinant </span>
   <span class="font12">Coxsackievirus </span>
   <span class="font12">... </span>
   <span class="font12">Newcastle </span>
   <span class="font12">Treatment </span>
   <span class="font12">growth </span>
   <span class="font12">potential </span>
   <span class="font12">response </span>
   <span class="font12">showed </span>
   <span class="font12">simplex </span>
   <span class="font12">stage </span>
   <span class="font11">[,]. </span>
   <span class="font11">demonstrated </span>
   <span class="font11">host </span>
   <span class="font11">including </span>
   <span class="font11">rate </span>
   <span class="font11">replication </span>
   <span class="font11">systemic </span>
   <span class="font11">trials </span>
   <span class="font11">Clinical </span>
   <span class="font11">DNA </span>
   <span class="font11">IL- </span>
   <span class="font11">applied </span>
   <span class="font11">local </span>
   <span class="font11">novel </span>
   <span class="font11">range </span>
   <span class="font11">results </span>
   <span class="font11">studies </span>
   <span class="font11">However, </span>
   <span class="font11">III </span>
   <span class="font11">Phase </span>
   <span class="font11">alphaviruses </span>
   <span class="font11">carcinoma </span>
   <span class="font11">cells, </span>
   <span class="font11">delivery </span>
   <span class="font11">receptor </span>
   <span class="font11">therapeutic </span>
   <span class="font11">treated </span>
   <span class="font11">tumors </span>
   <span class="font11">various </span>
   <span class="font11">ICAM- </span>
   <span class="font11">Using </span>
   <span class="font11">adenovirus </span>
   <span class="font11">apoptosis </span>
   <span class="font11">based </span>
   <span class="font11">chemotherapy </span>
   <span class="font11">development </span>
   <span class="font11">different </span>
   <span class="font11">dose </span>
   <span class="font11">effect </span>
   <span class="font11">lentiviral </span>
   <span class="font11">melanoma, </span>
   <span class="font11">melanoma. </span>
   <span class="font11">metastases </span>
   <span class="font11">model </span>
   <span class="font11">murine </span>
   <span class="font11">preclinical </span>
   <span class="font11">primary </span>
   <span class="font11">prostate </span>
   <span class="font11">protein </span>
   <span class="font11">px; </span>
   <span class="font11">regression </span>
   <span class="font11">ssRNA </span>
   <span class="font11">xenografts </span>
   <span class="font11">{font-family </span>
   <span class="font11">Trials </span>
   <span class="font11">adhesion </span>
   <span class="font11">application </span>
   <span class="font11">font-size </span>
   <span class="font11">immunotherapy </span>
   <span class="font11">induced </span>
   <span class="font11">intralesional </span>
   <span class="font11">intratumoral </span>
   <span class="font11">lentivirus </span>
   <span class="font11">observed </span>
   <span class="font11">overall </span>
   <span class="font11">particles </span>
   <span class="font11">promising </span>
   <span class="font11">reported </span>
   <span class="font11">strain </span>
   <span class="font11">study </span>
   <span class="font11">superior </span>
   <span class="font11">type </span>
   <span class="font11">Clin. </span>
   <span class="font11">HSV </span>
   <span class="font11">Immunol. </span>
   <span class="font11">PDT </span>
   <span class="font11">Preclinical </span>
   <span class="font11">Res. </span>
   <span class="font11">SFV </span>
   <span class="font11">Semliki </span>
   <span class="font11">Studies </span>
   <span class="font11">Virol../JVI...-. </span>
   <span class="font11">activity </span>
   <span class="font11">adeno-associated </span>
   <span class="font11">alphavirus </span>
   <span class="font11">attractive </span>
   <span class="font11">combined </span>
   <span class="font11">cutaneous </span>
   <span class="font11">cytotoxic </span>
   <span class="font11">double; </span>
   <span class="font11">effects </span>
   <span class="font11">engineered </span>
   <span class="font11">factor </span>
   <span class="font11">immunity </span>
   <span class="font11">immunization </span>
   <span class="font11">inhibits </span>
   <span class="font11">known </span>
   <span class="font11">like </span>
   <span class="font11">lines </span>
   <span class="font11">long-term </span>
   <span class="font11">lower </span>
   <span class="font11">melanoma: </span>
   <span class="font11">modified </span>
   <span class="font11">monotherapy </span>
   <span class="font11">multiple </span>
   <span class="font11">order </span>
   <span class="font11">provided </span>
   <span class="font11">rabies </span>
   <span class="font11">reduced </span>
   <span class="font11">replicon </span>
   <span class="font11">represents </span>
   <span class="font11">shown </span>
   <span class="font11">solid </span>
   <span class="font11">therapy. </span>
   <span class="font11">transfer </span>
   <span class="font11">transformed </span>
   <span class="font11">treatment. </span>
   <span class="font11">used </span>
   <span class="font11">viruses, </span>
   <span class="font11">vivo </span>
   <span class="font10">Alphaviruses </span>
   <span class="font10">DAF </span>
   <span class="font10">Engl. </span>
   <span class="font10">HSV- </span>
   <span class="font10">Med../NEJMoa </span>
   <span class="font10">New </span>
   <span class="font10">Ras </span>
   <span class="font10">Res../-.CCR-- </span>
   <span class="font10">Rev. </span>
   <span class="font10">SIN </span>
   <span class="font10">Virus </span>
   <span class="font10">[], </span>
   <span class="font10">[]Liver </span>
   <span class="font10">antigens </span>
   <span class="font10">applications </span>
   <span class="font10">approach </span>
   <span class="font10">autologous </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad </span>
   <span class="font10">colorectal </span>
   <span class="font10">compared </span>
   <span class="font10">conducted </span>
   <span class="font10">confirmed </span>
   <span class="font10">conventional </span>
   <span class="font10">days </span>
   <span class="font10">enhanced </span>
   <span class="font10">expressed </span>
   <span class="font10">forest </span>
   <span class="font10">glioma </span>
   <span class="font10">group </span>
   <span class="font10">improved </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitors </span>
   <span class="font10">injection </span>
   <span class="font10">ipilimumab </span>
   <span class="font10">killing </span>
   <span class="font10">lung </span>
   <span class="font10">lymph </span>
   <span class="font10">lysis </span>
   <span class="font10">models </span>
   <span class="font10">molecular </span>
   <span class="font10">mouse </span>
   <span class="font10">obtained </span>
   <span class="font10">orthotopic </span>
   <span class="font10">patient </span>
   <span class="font10">previously </span>
   <span class="font10">proliferation </span>
   <span class="font10">provide </span>
   <span class="font10">reoviruses </span>
   <span class="font10">resulted </span>
   <span class="font10">safety </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">systems </span>
   <span class="font10">transduction </span>
   <span class="font10">tumors, </span>
   <span class="font10">types </span>
   <span class="font10">unresectable </span>
   <span class="font10">vitro </span>
   <span class="font10">weeks </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Brain </span>
   <span class="font10">Broad </span>
   <span class="font10">CAR-T </span>
   <span class="font10">Current </span>
   <span class="font10">Forest </span>
   <span class="font10">Med. </span>
   <span class="font10">Oncol../S-()- </span>
   <span class="font10">Rep../or.. </span>
   <span class="font10">Table </span>
   <span class="font10">Ther../gt.. </span>
   <span class="font10">Ther../mt.. </span>
   <span class="font10">[,] </span>
   <span class="font10">[]Prostate </span>
   <span class="font10">according </span>
   <span class="font10">activation </span>
   <span class="font10">active </span>
   <span class="font10">age </span>
   <span class="font10">agents </span>
   <span class="font10">animal </span>
   <span class="font10">antitumor </span>
   <span class="font10">associated </span>
   <span class="font10">attachment </span>
   <span class="font10">bold </span>
   <span class="font10">candidate </span>
   <span class="font10">capacity </span>
   <span class="font10">carrying </span>
   <span class="font10">certain </span>
   <span class="font10">courier; </span>
   <span class="font10">dendritic </span>
   <span class="font10">did </span>
   <span class="font10">drug </span>
   <span class="font10">drugs </span>
   <span class="font10">dsDNA </span>
   <span class="font10">em; </span>
   <span class="font10">encoding </span>
   <span class="font10">enhances </span>
   <span class="font10">genetic </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">improve </span>
   <span class="font10">increased </span>
   <span class="font10">induction </span>
   <span class="font10">inhibition </span>
   <span class="font10">injected </span>
   <span class="font10">intravenous </span>
   <span class="font10">kinase </span>
   <span class="font10">laherparepvec </span>
   <span class="font10">load </span>
   <span class="font10">melanomas </span>
   <span class="font10">months </span>
   <span class="font10">necrosis </span>
   <span class="font10">objective </span>
   <span class="font10">pancreatic </span>
   <span class="font10">photodynamic </span>
   <span class="font10">protection </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">results, </span>
   <span class="font10">role </span>
   <span class="font10">signaling </span>
   <span class="font10">significant </span>
   <span class="font10">standard </span>
   <span class="font10">study, </span>
   <span class="font10">sun </span>
   <span class="font10">therapy: </span>
   <span class="font10">therapyJ. </span>
   <span class="font10">tolerated </span>
   <span class="font10">transduced </span>
   <span class="font10">trial, </span>
   <span class="font10">vaccination </span>
   <span class="font10">virus-based </span>
  </p>
 </body>
</html>
